VVP
PACB icon

Venture Visionary Partners’s Pacific Biosciences PACB Stock Holding History

Venture Visionary Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9K Hold
30,300
– – ﹤0.01% 701
2026
Q1 		$40K Hold
30,300
– – ﹤0.01% 633
2025
Q4 		$56.7K Hold
30,300
– – ﹤0.01% 629
2025
Q3 		$38.8K Hold
30,300
– – ﹤0.01% 617
2025
Q2 		$37.6K Buy
30,300
+300
+1% +$346 ﹤0.01% 595
2025
Q1 		$35.4K Hold
30,000
– – ﹤0.01% 565
2024
Q4 		$54.9K Buy
+30,000
New +$58.6K ﹤0.01% 538

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Venture Visionary Partners's PACB Position: Q2 2026 in Review

Venture Visionary Partners held its Pacific Biosciences (PACB) position steady in Q2 2026 at 30,300 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Venture Visionary Partners first reported a position in PACB in Q4 2024 and has held it in 7 quarters since. The position peaked at $56.7K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Venture Visionary Partners held 30,300 shares of Pacific Biosciences worth $50.9K as of Q2 2026.
  • Venture Visionary Partners left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Venture Visionary Partners's portfolio in Q2 2026, its #701 holding.
  • Venture Visionary Partners first reported a position in Pacific Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Venture Visionary Partners's Pacific Biosciences position peaked at $56.7K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.